Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ DEFINITION ++ Mycosis fungoides (MF) and its variant Sézary syndrome, the two principal types of cutaneous T-cell lymphoma (CTCL), are malignant proliferations of mature memory T lymphocytes of the phenotype CD4+CD45RO+ (memory T cells), which invariably involve the skin. Other types of lymphoma may also have prominent skin involvement (Table 66–1). ++Table Graphic Jump LocationTABLE 66–1WORLD HEALTH ORGANIZATION–EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CLASSIFICATION OF PRIMARY CUTANEOUS T-CELL AND NATURAL KILLER CELL LYMPHOMASView Table||Download (.pdf) TABLE 66–1 WORLD HEALTH ORGANIZATION–EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CLASSIFICATION OF PRIMARY CUTANEOUS T-CELL AND NATURAL KILLER CELL LYMPHOMAS Cutaneous T-cell lymphoma (CTCL) Mycosis fungoides (MF) MF variants Folliculotropic MF Pagetoid reticulosis Granulomatous slack skin Sézary syndrome Adult T-cell leukemia/lymphoma Primary cutaneous CD30+ lymphoproliferative disorders Primary cutaneous anaplastic large-cell lymphoma Lymphomatoid papulosis Subcutaneous panniculitis-like T-cell lymphoma Extranodal natural killer/T-cell lymphoma, nasal type Chronic active Epstein-Barr virus infection Primary cutaneous peripheral T-cell lymphoma, rare subtypes Primary cutaneous γ-δT-cell lymphoma Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma (provisional) Primary cutaneous CD4+ small/medium-size pleomorphic T-cell lymphoproliferative disorder (provisional) Primary cutaneous acral CD8+ T-cell lymphoma (provisional) Primary cutaneous peripheral T-cell lymphoma, not otherwise specified +++ EPIDEMIOLOGY ++ CTCL is more common in males than females. Median age at diagnosis is 55 years. In the United States, there are approximately 3000 cases per year, representing about 2% of lymphomas. The annual incidence is approximately 1 per 100,000. Americans of African descent have a higher incidence and more progressive disease than Americans of European descent. Asians and Hispanics are much less often affected. The etiology is unknown. +++ CLINICAL FINDINGS ++ Patients usually present with nonspecific skin lesions (chronic dermatitis) occurring years before diagnosis. Early in disease, patients are often diagnosed with eczema (spongiotic dermatitis), psoriatic-like dermatitis, or other nonspecific dermatoses associated with pruritus. In early stages of the disease, the lesions may wax and wane. Histologic diagnosis may be difficult in early stages. Neoplastic infiltrates may be minimal, masked by normal inflammatory cells, and the neoplastic mature CD4+ phenotype may be misinterpreted as normal inflammatory cells. MF may be divided into patch stage (patch-only disease), plaque stage (both patches and plaques), and tumor stage (more than one tumor along with patches and plaques). A patch is defined as a flat lesion with varying degrees of erythema with fine scaling; a plaque is defined as a demarcated, erythematous, brownish lesion, with variable scaling of at least 1 mm elevation above the skin surface; and a tumor extends at least 5 mm above the surface (tumors are usually in a setting of patches and plaques) (Figure 66–1). Lesions have a predisposition for skin folds and non–sun-exposed areas (bathing-trunk distribution), but in later stages, they can be generalized and involve the face, palms, soles, and other areas. Progression through stages usually occurs over years, but some cases ... Your Access profile is currently affiliated with '[InstitutionA]' and is in the process of switching affiliations to '[InstitutionB]'. Please click ‘Continue’ to continue the affiliation switch, otherwise click ‘Cancel’ to cancel signing in. Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Username Error: Please enter User Name Password Error: Please enter Password Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth